Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig B Langman

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Kidney International|May 17, 2016
Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceCraig B Langman, Bruce A Barshop, Georges Deschênes, et al.
Kidney International|September 5, 2021
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluriaBernd Hoppe, Annelize Koch, Pierre Cochat, et al.
Pediatric Nephrology (Berlin, Germany)|June 21, 2019
Serum albumin and hospitalization among pediatric patients with end-stage renal disease who started dialysis therapyYusuke Okuda, Yoshitsugu Obi, Elani Streja, et al.
Arthritis and Rheumatism|October 1, 2009
25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosusPeggy W Wu, Elisa Y Rhew, Alan R Dyer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2014
Medication adherence and growth in children with CKDOleh M Akchurin, Michael F Schneider, Lucy Mulqueen, et al.
Journal of Endourology|February 19, 2020
Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus StatementBrian H Eisner, David S Goldfarb, Michelle A Baum, et al.
The Journal of Pediatrics|June 21, 2014
Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrateCraig B Langman, Larry A Greenbaum, Paul Grimm, et al.
Implementation Science Communications|August 25, 2020
Optimizing the implementation of a population panel management intervention in safety-net clinics for pediatric hypertension (The OpTIMISe-Pediatric Hypertension Study)Justin D Smith, Nivedita Mohanty, Matthew M Davis, et al.
Pediatric Nephrology (Berlin, Germany)|February 10, 2009
A position statement on kidney disease from powdered infant formula-based melamine exposure in Chinese infantsCraig B Langman, Uri Alon, Julie Ingelfinger, et al.
Pediatric Research|June 26, 2013
Longitudinal trajectory of vitamin D status from birth to early childhood in the development of food sensitizationXin Liu, Lester Arguelles, Ying Zhou, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Kidney International|May 17, 2016
Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceCraig B Langman, Bruce A Barshop, Georges Deschênes, et al.
Kidney International|September 5, 2021
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluriaBernd Hoppe, Annelize Koch, Pierre Cochat, et al.
Pediatric Nephrology (Berlin, Germany)|June 21, 2019
Serum albumin and hospitalization among pediatric patients with end-stage renal disease who started dialysis therapyYusuke Okuda, Yoshitsugu Obi, Elani Streja, et al.
Arthritis and Rheumatism|October 1, 2009
25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosusPeggy W Wu, Elisa Y Rhew, Alan R Dyer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2014
Medication adherence and growth in children with CKDOleh M Akchurin, Michael F Schneider, Lucy Mulqueen, et al.
Journal of Endourology|February 19, 2020
Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus StatementBrian H Eisner, David S Goldfarb, Michelle A Baum, et al.
The Journal of Pediatrics|June 21, 2014
Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrateCraig B Langman, Larry A Greenbaum, Paul Grimm, et al.
Implementation Science Communications|August 25, 2020
Optimizing the implementation of a population panel management intervention in safety-net clinics for pediatric hypertension (The OpTIMISe-Pediatric Hypertension Study)Justin D Smith, Nivedita Mohanty, Matthew M Davis, et al.
Pediatric Nephrology (Berlin, Germany)|February 10, 2009
A position statement on kidney disease from powdered infant formula-based melamine exposure in Chinese infantsCraig B Langman, Uri Alon, Julie Ingelfinger, et al.
Pediatric Research|June 26, 2013
Longitudinal trajectory of vitamin D status from birth to early childhood in the development of food sensitizationXin Liu, Lester Arguelles, Ying Zhou, et al.
Pageof 12